Clinical Trial Update: Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing vasopressin to norepinephrine for septic shock in cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)
• VASOPRESSIN (VASOPRESSIN)

Snippet

Sponsor: Instituto do Cancer do Estado de São Paulo | Conditions: Septic Shock | Phase 3 | Status: COMPLETED